Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PrognomiQ launches ProVue Lung, a novel proteomics-based Laboratory Developed Test (LDT) to help improve detection of lung cancer at its earliest stages.
-
HOUSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in genome sequencing...
-
LIZBONA, Portugalia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Jedno z najbardziej przełomowych rozwiązań w zakresie cyfrowej opieki zdrowotnej będzie dostępne w Polsce. Medāna (www.medana.ai), globalna...
-
Poland is about to welcome one of the most disruptive innovations in digital health. Medāna announced its strategic entry into the Polish healthcare market
-
LISBOA, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- España está a punto de recibir una de las tecnologías más disruptivas en salud digital. Medāna (www.medana.ai), startup internacional fundada...
-
LA EMPRESA CON SEDE EN LISBOA Y RESPALDADA POR FINANCIACIÓN ESTRATÉGICA, INICIA SU EXPANSIÓN EN ESPAÑA CON UN MODELO COLABORATIVO E INNOVADOR
-
LISSABON, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- Nederland staat op het punt een van de meest baanbrekende technologieën in de digitale gezondheidszorg te verwelkomen. Medāna...
-
Netherlands is about to welcome one of the most disruptive technologies in digital health. Medāna has announced its strategic entry into healthcare market.
-
PrognomiQ Announces the appointment of Joel Kaufman as Chief Financial Officer, serving on the company's Executive Team.
-
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform